[SCHEDULE 13G/A] Applied DNA Sciences, Inc. SEC Filing
Applied DNA Sciences (APDN) discloses that a group of affiliated investment entities and individuals led by Anson controls 573,538 shares, representing 8.2% of the outstanding common stock on a diluted basis including warrants. The filing states the position is held in the ordinary course of business and not for the purpose of changing control. Shared voting and dispositive power over the 573,538 shares is reported, with no sole voting or dispositive power claimed. The filing identifies the reporting persons and their organizational domiciles and clarifies warrant exercise limitations considered in the ownership percentage.
Applied DNA Sciences (APDN) comunica che un insieme di soggetti collegati e investitori guidati da Anson detiene 573.538 azioni, pari a 8,2% del capitale sociale in circolazione su base diluita, inclusi i warrant. La dichiarazione specifica che la posizione 猫 detenuta nell'ordinario svolgimento dell'attivit脿 e non con l'intento di modificare il controllo. Viene riportato il potere di voto e il potere dispositivio congiunto sulle 573.538 azioni, senza rivendicare poteri esclusivi di voto o dispositivi. Il documento identifica le persone che presentano la comunicazione, le loro sedi organizzative e precisa le limitazioni all'esercizio dei warrant considerate nel calcolo della percentuale di partecipazione.
Applied DNA Sciences (APDN) revela que un grupo de entidades e individuos vinculados, encabezados por Anson, controla 573.538 acciones, lo que representa 8,2% del capital social en circulaci贸n en base diluida, incluidos los warrants. El informe indica que la posici贸n se mantiene en el curso ordinario del negocio y no con el prop贸sito de cambiar el control. Se informa poder de voto y poder dispositvo compartido sobre las 573.538 acciones, sin reclamar poderes exclusivos de voto o dispositivos. El documento identifica a los declarante y sus domicilios organizativos y aclara las limitaciones de ejercicio de los warrants consideradas en el porcentaje de propiedad.
Applied DNA Sciences (APDN)電� Anson鞚� 欤茧弰頃橂姅 瓿勳棿 韴瀽 雼泊 氚� 臧滌澑霌れ澊 573,538欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 鞗岆煱韸鸽ゼ 韽暔頃� 頋劃 旮办鞙茧 鞙犿喌 氤错喌欤� 8.2%鞐� 頃措嫻頃滊嫟瓿� 瓿奠嫓頄堨姷雼堧嫟. 鞝滌稖靹滊電� 頃措嫻 歆�攵勳澊 鞓侅梾頇滊彊鞚� 鞚柬櫂鞙茧 氤挫湢霅� 瓴冹澊氅� 歆�氚瓣秾 氤�瓴届潉 氇╈爜鞙茧 頃� 瓴冹澊 鞎勲媹霛缄碃 氇呾嫓頃╇媹雼�. 573,538欤检棎 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岇澊 氤搓碃霅橃棃瓿�, 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潃 欤检灔霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖鞛愲姅 氤搓碃鞛愲摛瓿� 攴鸽摛鞚� 臁办 靻岇灛歆�毳� 氚濏瀳瓿�, 歆�攵� 牍勳湪 靷办爼鞐� 氚橃榿霅� 鞗岆煱韸� 頄夓偓 鞝滍暅 靷暛鞚� 氇呿檿頌� 頄堨姷雼堧嫟.
Applied DNA Sciences (APDN) r茅v猫le qu'un groupe d'entit茅s et d'individus affili茅s, dirig茅 par Anson, contr么le 573 538 actions, soit 8,2 % du capital social en circulation sur une base dilu茅e, warrants inclus. Le d茅p么t indique que la position est d茅tenue dans le cours normal des affaires et non dans le but de modifier le contr么le. Un pouvoir de vote et de disposition partag茅 sur les 573 538 actions est d茅clar茅, sans pr茅tendre 脿 un pouvoir exclusif de vote ou de disposition. Le document identifie les personnes d茅clarantes et leurs domiciles organisationnels et pr茅cise les limitations d'exercice des warrants prises en compte dans le calcul du pourcentage de d茅tention.
Applied DNA Sciences (APDN) gibt bekannt, dass eine Gruppe verbundener Investmentgesellschaften und Personen unter der Leitung von Anson 573.538 Aktien h盲lt, was auf verw盲sserter Basis einschlie脽lich Warrants 8,2 % des ausstehenden Stammkapitals entspricht. Die Meldung stellt klar, dass die Position im normalen Gesch盲ftsbetrieb gehalten wird und nicht mit dem Ziel einer Kontroll盲nderung. Es wird gemeinsames Stimm- und Verf眉gungsrecht 眉ber die 573.538 Aktien angegeben; ausschlie脽liche Stimm- oder Verf眉gungsrechte werden nicht geltend gemacht. Die Einreichung benennt die meldenden Personen und deren organisatorische Sitzorte und erl盲utert die bei der Berechnung des Eigentumsanteils ber眉cksichtigten Einschr盲nkungen bei der Aus眉bung von Warrants.
- Material disclosure of a >5% stake (573,538 shares, 8.2% diluted) provides clarity to investors
- Position reported as passive under Schedule 13G, indicating no declared intent to change control
- None.
Insights
TL;DR: Anson group holds an 8.2% diluted stake in APDN with shared voting power; position reported as passive.
The disclosure shows a notable passive stake above the 5% threshold, which can attract investor attention without signaling control intentions. The 8.2% figure is calculated on a diluted base including warrants and factors in ownership limitations that cap exercise to 4.99% or 9.99% for certain warrants. Shared voting and dispositive power indicates coordinated influence among the reporting persons rather than unilateral control. Because the filing is a Schedule 13G, the group asserts passive intent, reducing immediate governance implications but making the stake material for market watchers and potential future activist interest.
TL;DR: Group ownership is material but claimed passive; shared authority may warrant monitoring for future changes in intent.
The filing identifies multiple affiliated entities and individuals with shared control over the position, and it explicitly states the securities were not acquired to influence control. This classification under Schedule 13G signals no current intent to pursue board or control actions. The inclusion of warrant-based dilution and exercise limitations is important for governance analysis because actual voting influence could change if warrants are exercised subject to the stated ceilings. Investors concerned with board composition should note the combined ownership and the potential for coordinated action despite the passive claim.
Applied DNA Sciences (APDN) comunica che un insieme di soggetti collegati e investitori guidati da Anson detiene 573.538 azioni, pari a 8,2% del capitale sociale in circolazione su base diluita, inclusi i warrant. La dichiarazione specifica che la posizione 猫 detenuta nell'ordinario svolgimento dell'attivit脿 e non con l'intento di modificare il controllo. Viene riportato il potere di voto e il potere dispositivio congiunto sulle 573.538 azioni, senza rivendicare poteri esclusivi di voto o dispositivi. Il documento identifica le persone che presentano la comunicazione, le loro sedi organizzative e precisa le limitazioni all'esercizio dei warrant considerate nel calcolo della percentuale di partecipazione.
Applied DNA Sciences (APDN) revela que un grupo de entidades e individuos vinculados, encabezados por Anson, controla 573.538 acciones, lo que representa 8,2% del capital social en circulaci贸n en base diluida, incluidos los warrants. El informe indica que la posici贸n se mantiene en el curso ordinario del negocio y no con el prop贸sito de cambiar el control. Se informa poder de voto y poder dispositvo compartido sobre las 573.538 acciones, sin reclamar poderes exclusivos de voto o dispositivos. El documento identifica a los declarante y sus domicilios organizativos y aclara las limitaciones de ejercicio de los warrants consideradas en el porcentaje de propiedad.
Applied DNA Sciences (APDN)電� Anson鞚� 欤茧弰頃橂姅 瓿勳棿 韴瀽 雼泊 氚� 臧滌澑霌れ澊 573,538欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 鞗岆煱韸鸽ゼ 韽暔頃� 頋劃 旮办鞙茧 鞙犿喌 氤错喌欤� 8.2%鞐� 頃措嫻頃滊嫟瓿� 瓿奠嫓頄堨姷雼堧嫟. 鞝滌稖靹滊電� 頃措嫻 歆�攵勳澊 鞓侅梾頇滊彊鞚� 鞚柬櫂鞙茧 氤挫湢霅� 瓴冹澊氅� 歆�氚瓣秾 氤�瓴届潉 氇╈爜鞙茧 頃� 瓴冹澊 鞎勲媹霛缄碃 氇呾嫓頃╇媹雼�. 573,538欤检棎 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岇澊 氤搓碃霅橃棃瓿�, 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潃 欤检灔霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖鞛愲姅 氤搓碃鞛愲摛瓿� 攴鸽摛鞚� 臁办 靻岇灛歆�毳� 氚濏瀳瓿�, 歆�攵� 牍勳湪 靷办爼鞐� 氚橃榿霅� 鞗岆煱韸� 頄夓偓 鞝滍暅 靷暛鞚� 氇呿檿頌� 頄堨姷雼堧嫟.
Applied DNA Sciences (APDN) r茅v猫le qu'un groupe d'entit茅s et d'individus affili茅s, dirig茅 par Anson, contr么le 573 538 actions, soit 8,2 % du capital social en circulation sur une base dilu茅e, warrants inclus. Le d茅p么t indique que la position est d茅tenue dans le cours normal des affaires et non dans le but de modifier le contr么le. Un pouvoir de vote et de disposition partag茅 sur les 573 538 actions est d茅clar茅, sans pr茅tendre 脿 un pouvoir exclusif de vote ou de disposition. Le document identifie les personnes d茅clarantes et leurs domiciles organisationnels et pr茅cise les limitations d'exercice des warrants prises en compte dans le calcul du pourcentage de d茅tention.
Applied DNA Sciences (APDN) gibt bekannt, dass eine Gruppe verbundener Investmentgesellschaften und Personen unter der Leitung von Anson 573.538 Aktien h盲lt, was auf verw盲sserter Basis einschlie脽lich Warrants 8,2 % des ausstehenden Stammkapitals entspricht. Die Meldung stellt klar, dass die Position im normalen Gesch盲ftsbetrieb gehalten wird und nicht mit dem Ziel einer Kontroll盲nderung. Es wird gemeinsames Stimm- und Verf眉gungsrecht 眉ber die 573.538 Aktien angegeben; ausschlie脽liche Stimm- oder Verf眉gungsrechte werden nicht geltend gemacht. Die Einreichung benennt die meldenden Personen und deren organisatorische Sitzorte und erl盲utert die bei der Berechnung des Eigentumsanteils ber眉cksichtigten Einschr盲nkungen bei der Aus眉bung von Warrants.
FAQ
How many APDN shares does Anson report beneficially owning?
What percentage of APDN does the Anson group own?
Does the filing indicate Anson intends to influence control of APDN?
Do the reporting persons hold sole voting power over the shares?
Are warrants included in the ownership calculation?
